CV Sciences, Inc. Repays Remaining Debt
22 août 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable...
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
01 août 2018 08h45 HE
|
CV Sciences, Inc.
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 MillionManagement to Host Second Quarter 2018 Financial Results Conference Call on August...
CV Sciences, Inc. to Host Annual Meeting of Shareholders and Investor Day on August 4, 2018 in San Diego, California
10 juil. 2018 08h45 HE
|
CV Sciences, Inc.
Company to Feature Guest Speaker, World-Renowned Neurosurgeon and Sports Medicine Expert Dr. Joseph Maroon LAS VEGAS, July 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the...
CV Sciences, Inc. Issues Letter to Shareholders
27 juin 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the industry-dominating brand...
CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of Base Material of its PlusCBD Oil™ Products
15 juin 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, June 15, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today the June 7, 2018 publication of the toxicology and safety...
CV Sciences, Inc. Settles SEC Matter
01 juin 2018 08h45 HE
|
CV Sciences, Inc.
The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV Sciences, Inc. Supports World No Tobacco Day on May 31, 2018
31 mai 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, May 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), is pleased to announce its support in highlighting the World Health...
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
22 mai 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp...
CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018
08 mai 2018 05h45 HE
|
CV Sciences, Inc.
LAS VEGAS, May 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) a preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is...
CV Sciences, Inc. Fully Retires Convertible Debt
25 avr. 2018 11h08 HE
|
CV Sciences, Inc.
Company Fully Repays Outstanding Convertible Debt and Avoids Dilution to Stockholders LAS VEGAS, April 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,”...